ID: ALA192540

Max Phase: Preclinical

Molecular Formula: C18H20O

Molecular Weight: 252.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(/C=C\c2cc(C)c(C)c(C)c2)cc1

Standard InChI:  InChI=1S/C18H20O/c1-13-11-17(12-14(2)15(13)3)6-5-16-7-9-18(19-4)10-8-16/h5-12H,1-4H3/b6-5-

Standard InChI Key:  SXBHAAVNYFTFJG-WAYWQWQTSA-N

Associated Targets(Human)

Tubulin beta-1 chain 182 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 252.36Molecular Weight (Monoisotopic): 252.1514AlogP: 4.79#Rotatable Bonds: 3
Polar Surface Area: 9.23Molecular Species: NEUTRALHBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 5.70CX LogD: 5.70
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.71Np Likeness Score: -0.04

References

1. Ducki S, Mackenzie G, Lawrence NJ, Snyder JP..  (2005)  Quantitative structure-activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly.,  48  (2): [PMID:15658859] [10.1021/jm049444m]

Source